{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "17604512", "DateCompleted": {"Year": "2008", "Month": "11", "Day": "24"}, "DateRevised": {"Year": "2018", "Month": "11", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": [], "Journal": {"ISSN": "1729-0503", "JournalIssue": {"Volume": "6", "Issue": "4", "PubDate": {"Year": "2006", "Month": "Dec"}}, "Title": "African health sciences", "ISOAbbreviation": "Afr Health Sci"}, "ArticleTitle": "Antimicrobial activity against gram negative bacilli from Yaounde Central Hospital, Cameroon.", "Pagination": {"StartPage": "232", "EndPage": "235", "MedlinePgn": "232-5"}, "Abstract": {"AbstractText": ["Antimicrobial resistance among bacteria pathogens is a world-wide issue. The antimicrobial susceptibility patterns of common pathogenic bacteria are essential to guide empirical and pathogen-specific therapy; unfortunately, these data are scarse in Cameroon.", "To determine the antimicrobial susceptibility patterns of Gram-negative bacilli isolated in Yaounde Central Hospital Laboratory of Bacteriology.", "Gram-negative bacilli isolates (n = 505), obtained from a wide range of clinical specimens (urine, pus and blood) in Yaound\u00e9 Central Hospital Laboratory of Bacteriology between March 1995 and April 1998, were evaluated for resistance to antibiotics (amoxicillin, amoxicillin/clavulanate, piperacillin, cefazolin, cefoxitin, cefotaxime, ceftazidime, aztreonam, imipenem, gentamicin, tobramicin, ofloxacin and trimethoprim/sulfamethoxazole) by the Kirby-Bauer disk diffusion method.", "High rates of resistance were found in most of the bacteria studied. Resistance to all isolates was mostly observed for amoxicillin (87%), piperacillin (74%) and trimethoprim/sulfamethoxazole (73%). Susceptibilities to third generation cephalosporins (cefotaxime, ceftazidime) and monobactame (aztreonam) were = 91% for Escherichia coli, = 71% for Klebsiella spp., = 98% for Proteus mirabilis, = 50% for Enterobacter spp. and Citrobacter spp. Pseudomonas aeruginosa was less susceptible to cefotaxime (2%) and aztreonam (33%), and highly susceptible to ceftazidime (72%) whereas Acinetobacter baumannii was highly resistant to aztreonam (100%), to cefotaxime (96%) and cetazidime (62%). Imipenem (98%) was the most active antibiotic followed by the ofloxacine (88%). Susceptibility of all isolates to gentamicin was 67%.", "These results indicate that surveillance to antimicrobial resistance in Cameroon is necessary to monitor microbial trends, antimicrobial resistance pattern, and provide information for choosing empirical or direct therapy to physicians."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Medical Research and Medicinal Plants studies, Yaounde, Cameroon. jgangoue@yahoo.fr"}], "Identifier": [], "LastName": "Gangoue-Pieboji", "ForeName": "Joseph", "Initials": "J"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Koulla-Shiro", "ForeName": "Sinata", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ngassam", "ForeName": "Pierre", "Initials": "P"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Adiogo", "ForeName": "Dieudonne", "Initials": "D"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ndumbe", "ForeName": "Peter", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Uganda", "MedlineTA": "Afr Health Sci", "NlmUniqueID": "101149451", "ISSNLinking": "1680-6905"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Infective Agents"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology", "therapeutic use"], "DescriptorName": "Anti-Infective Agents"}, {"QualifierName": [], "DescriptorName": "Cameroon"}, {"QualifierName": [], "DescriptorName": "Drug Resistance, Bacterial"}, {"QualifierName": ["drug effects", "isolation & purification"], "DescriptorName": "Gram-Negative Bacteria"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Microbial Sensitivity Tests"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial surveillance program, 1997. Clin Infect Dis. 1999;29:595\u2013607.", "ArticleIdList": ["10530454"]}, {"Citation": "Livermore DM. \u00e2-lactamases in laboratory and clinical resistance. Clin Microb Rev. 1995;8:557\u2013584.", "ArticleIdList": ["PMC172876", "8665470"]}, {"Citation": "Gangou\u00e9-Pi\u00e9boji J. R\u00e9sistance des bacilles a gram-n\u00e9gatif aux antibiotiques: pr\u00e9valence et caract\u00e9risation des \u00e2-lactamases a spectre \u00e9largi a l'hopital Central de Yaound\u00e9. Universit\u00e9 de Yaound\u00e9 I; 2000. p. 210. Th\u00e8se de Doctorat de 3e cycle."}, {"Citation": "Cosgrove SE, Kaye KS, Eliopoulos GM, Carmeli Y. Health and economic outcomes of the emergence of thirdgeneration cephalosporin resistance in Enterobacter species. Arch Intern Med. 2002;162:185\u2013190.", "ArticleIdList": ["11802752"]}, {"Citation": "Wise R, Hart T, Cars O, Streuleus M, Helmut, Huovinen P. Antimicrobial resistance is a major threat to public health. British Med J. 1998;317:609\u2013610.", "ArticleIdList": ["PMC1113826", "9727981"]}, {"Citation": "Shaes DM, Gerdin DN, John JF, Jr, Craig WA, Borstein DL, Ducan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases of America Committee on the prevention of antimicrobial resistance. Clin Infec Dis. 1997;25:584\u2013599.", "ArticleIdList": ["9314444"]}, {"Citation": "Farmer JJ, II, Kelly MT. Enterobacteriaceae. In: Lenette EH, Balows A, Hausler WJ, Shadomy HJ, editors. Manual of clinical Microbiology. Washington DC: American Society for Microbiology; 1991. pp. 360\u2013383."}, {"Citation": "National Committee for Clinical Laboratory Standards, author. Performance standards for antimicrobial disk susceptibility tests. Approved standard M2 A6 (M100-S7) Wagne, PA: NCCLS; 1997."}, {"Citation": "Gangou\u00e9-Pi\u00e9boji J, Koulla-Shiro S, Ngassam P, Adiogo D, Njine T, Ndumbe P. Antimicrobial resistance of Gram-negative bacilli isolates form inpatients and outpatients at Yaounde Central Hospital, Cameroon. Inter J Infect Dis. 2004;8:147\u2013154.", "ArticleIdList": ["15109589"]}, {"Citation": "Wenzel RP, Sahm DF, Thornsberry C, Draghi DC, Jones ME, Karlowsky JA. In vitro susceptibilities of gram-negative bacteria isolated from hospitalized patients in four European countries, Canada, and the United States in 2000\u20132001 to expanded spectrum cephalosporin and comparator antimicrobials: Implications for therapy. Antimicrob Agents Chemother. 2003;47:3089\u20133098.", "ArticleIdList": ["PMC201113", "14506014"]}, {"Citation": "Kahlmeter G. An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO-SENS project. J Antimicrob Chemother. 2003;51:69\u201376.", "ArticleIdList": ["12493789"]}, {"Citation": "El Kholy A, Baseem H, Hall GS, Procop GW, Longworth DL. Antimicrobial resistance in Cairo, Egypt 1999\u20132000: a survey of five hospitals. J Antimicrob Chemother. 2003;51:625\u2013630.", "ArticleIdList": ["12615864"]}, {"Citation": "Karlowsky JA, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Trends in antimicrobial susceptibilities among enterobacteriaceae isolated from hospitalized patients in the United States from 1998 to 2001. Antimicrob Agents Chemother. 2003;47:1672\u20131680.", "ArticleIdList": ["PMC153325", "12709339"]}, {"Citation": "Lamikamra A, Ndep RB. Trimethoprim resistance in urinary tract pathogens in two Nigeria hospitals. J Antimicrob Chemother. 1989;23:151\u2013154.", "ArticleIdList": ["2745248"]}, {"Citation": "Koulla-Shiro S, Boye CS, Dosso M, the members of the palm project . Surveillance of antimicrobial susceptibility of gram-negative pathogens responsible for nosocomial infections in West Africa (Abstract number E-95) San Diego, California: 42nd ICAAC; 1998. p. 197."}, {"Citation": "Huovinen P, Sundstr\u00f6m L, Swedberg G, Sk\u00f6d O. Trimethoprim and sulfonamide resistance. Antimicrob Agents Chemother. 1995;39:279\u2013289.", "ArticleIdList": ["PMC162528", "7726483"]}, {"Citation": "Gales AC, Bolmstrom A, Sampaio J, Sader HS. Antimicrobial susceptibility of Klebsiella pneumoniae producing extended spectrum \u00e2-lactamase (ESBL) isolated in hospital in Brazil. Brazilian J Infec Dis. 1997;1:196\u2013203.", "ArticleIdList": ["11105137"]}, {"Citation": "Jones RN, Sader HS, Beach ML. Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative gram-negative bacilli isolated in the SENTRY antimicrobial surveillance program (1997\u20132001) Inter J Antimicrob Agents. 2003;22:551\u2013556.", "ArticleIdList": ["14659650"]}, {"Citation": "Karlowsky JA, Draghi DC, Jones ME, Thornsberry C, Friedland IR, Sahm DF. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States 1998 to 2001. Antimicrob Agents Chemother. 2003;47:1681\u20131688.", "ArticleIdList": ["PMC153334", "12709340"]}]}], "History": [{"Year": "2007", "Month": "7", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2008", "Month": "12", "Day": "17", "Hour": "9", "Minute": "0"}, {"Year": "2007", "Month": "7", "Day": "3", "Hour": "9", "Minute": "0"}, {"Year": "2006", "Month": "12", "Day": "1"}], "PublicationStatus": "ppublish", "ArticleIdList": ["17604512", "PMC1832069", "10.5555/afhs.2006.6.4.232"]}}], "PubmedBookArticle": []}